Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study.

Baldacci S, Figeac M, Antoine M, Descarpentries C, Kherrouche Z, Jamme P, Copin MC, Tulasne D, Nanni I, Beau-Faller M, Melaabi S, Levallet G, Quoix E, Moro-Sibilot D, Friard S, Missy P, Barlesi F, Cadranel J, Cortot AB.

J Thorac Oncol. 2020 Jan;15(1):120-124. doi: 10.1016/j.jtho.2019.09.196. Epub 2019 Oct 9.

PMID:
31605799
2.

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.

Mehlman C, Cadranel J, Rousseau-Bussac G, Lacave R, Pujals A, Girard N, Callens C, Gounant V, Théou-Anton N, Friard S, Trédaniel J, Blons H, Dujon C, Duchemann B, Schischmanoff PO, Chinet T, Giroux Leprieur E.

Lung Cancer. 2019 Nov;137:149-156. doi: 10.1016/j.lungcan.2019.09.019. Epub 2019 Sep 28.

PMID:
31600593
3.

Nivolumab-refractory patients with advanced non-small-cell lung cancer.

Costantini A, Fallet V, Corny J, Friard S, Chouaid C, Duchemann B, Giroux-Leprieur E, Taillade L, Doucet L, Brosseau S, Wislez M, Tredaniel J, Cadranel J.

Lung Cancer. 2019 Apr;130:128-134. doi: 10.1016/j.lungcan.2019.01.015. Epub 2019 Feb 14.

4.

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.

Meyer G, Besse B, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz PE, Revel MP, Westeel V, Dixmier A, Tredaniel J, Dehette S, Decroisette C, Prevost A, Pichon E, Fabre E, Soria JC, Friard S, Stern JB, Jabot L, Dennewald G, Pavy G, Petitpretz P, Tourani JM, Alifano M, Chatellier G, Girard P.

Eur Respir J. 2018 Oct 4;52(4). pii: 1801220. doi: 10.1183/13993003.01220-2018. Print 2018 Oct.

5.

Lorlatinib - Induced pulmonary arterial hypertension.

Chabrol A, Mayenga M, Hamid AM, Friard S, Salvator H, Doubre H, Fraboulet S, Metivier AC, Catherinot E, Rivaud E, Chaumais MC, Montani D, Couderc LJ, Tcherakian C.

Lung Cancer. 2018 Jun;120:60-61. doi: 10.1016/j.lungcan.2018.03.023. Epub 2018 Mar 27.

PMID:
29748016
6.

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer.

Costantini A, Corny J, Fallet V, Renet S, Friard S, Chouaid C, Duchemann B, Giroux-Leprieur E, Taillade L, Doucet L, Nguenang M, Jouveshomme S, Wislez M, Tredaniel J, Cadranel J.

ERJ Open Res. 2018 Apr 20;4(2). pii: 00120-2017. doi: 10.1183/23120541.00120-2017. eCollection 2018 Apr.

7.

Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.

Loubière S, Drezet A, Beau-Faller M, Moro-Sibilot D, Friard S, Wislez M, Blons H, Daniel C, Westeel V, Madroszyk A, Léna H, Merle P, Mazières J, Zalcman G, Lacave R, Antoine M, Morin F, Missy P, Barlesi F, Auquier P, Cadranel J; French Cooperative Thoracic Intergroup (IFCT).

Eur Respir J. 2018 Mar 15;51(3). pii: 1701467. doi: 10.1183/13993003.01467-2017. Print 2018 Mar.

8.

Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients.

Cadranel J, Cortot AB, Lena H, Mennecier B, Do P, Dansin E, Mazieres J, Chouaid C, Perol M, Barlesi F, Robinet G, Friard S, Thiberville L, Audigier-Valette C, Vergnenegre A, Westeel V, Slimane K, Buturuga A, Moro-Sibilot D, Besse B.

ERJ Open Res. 2018 Feb 13;4(1). pii: 00058-2017. doi: 10.1183/23120541.00058-2017. eCollection 2018 Jan.

9.

Lung cancer in renal transplant recipients: A case-control study.

Rousseau-Gazaniol C, Fraboulet S, Couderc LJ, Kreis H, Borie R, Tricot L, Anglicheau D, Martinez F, Doubre H, Bonnette P, Mellot F, Massiani MA, Pelle G, Sage E, Moisson P, Delahousse M, Zemoura L, Chapelier A, Hamid AM, Puyo P, Longchampt E, Legendre C, Friard S, Catherinot E.

Lung Cancer. 2017 Sep;111:96-100. doi: 10.1016/j.lungcan.2017.07.011. Epub 2017 Jul 11.

PMID:
28838407
10.

Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504.

Cadranel J, Gervais R, Merle P, Moro-Sibilot D, Westeel V, Bigay-Game L, Quoix E, Friard S, Barlesi F, Lethrosne C, Moreau L, Monnet I, Salaun M, Oliviero G, Souquet PJ, Antoine M, Langlais A, Morin F, Wislez M, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique (IFCT).

Eur Respir J. 2015 Nov;46(5):1440-50. doi: 10.1183/13993003.02358-2014. Epub 2015 Sep 17.

11.

Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature Review.

Créquit P, Wislez M, Fleury Feith J, Rozensztajn N, Jabot L, Friard S, Lavole A, Gounant V, Fillon J, Antoine M, Cadranel J.

J Thorac Oncol. 2015 Aug;10(8):1148-55. doi: 10.1097/JTO.0000000000000577.

12.

Efficacy and safety of gefitinib during pregnancy: case report and literature review.

Gil S, Goetgheluck J, Paci A, Broutin S, Friard S, Couderc LJ, Ayoubi JM, Picone O, Tcherakian C.

Lung Cancer. 2014 Sep;85(3):481-4. doi: 10.1016/j.lungcan.2014.06.003. Epub 2014 Jun 16. Review.

PMID:
24997732
13.

[Radiofrequency treatment of lung tumours].

Mellot F, Friard S, Doubre H, Guth A, Chapelier A, Scherrer A, Couderc LJ.

Rev Pneumol Clin. 2011 Sep;67(4):238-43. doi: 10.1016/j.pneumo.2011.04.003. Epub 2011 Aug 4. Review. French.

PMID:
21920284
14.

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3.

Borget I, Cadranel J, Pignon JP, Quoix E, Coudert B, Westeel V, Dansin E, Madelaine J, Madroszyk A, Friard S, Daniel C, Morin F, Chouaid C; ERMETIC Collaborative Group.

Eur Respir J. 2012 Jan;39(1):172-9. doi: 10.1183/09031936.00201210. Epub 2011 Jun 9.

15.

[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours].

Meyer G, Besse B, Friard S, Girard P, Corbi P, Azarian R, Monnet I, Alifano M, Chouaid C, Descourt R, Dennewald G, Taillade L, De Luca K, Giraud F, Pichon E, Chatellier G.

Rev Mal Respir. 2011 May;28(5):654-9. doi: 10.1016/j.rmr.2011.03.015. Epub 2011 Apr 29. French.

PMID:
21645836
16.

Improvement of psoriasis in a lung cancer patient treated with erlotinib.

Giroux Leprieur E, Friard S, Couderc LJ.

Eur J Dermatol. 2010 Mar-Apr;20(2):243-4. doi: 10.1684/ejd.2010.0882. Epub 2010 Feb 2. No abstract available.

PMID:
20123646
17.

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, Chagué D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Rémy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefébure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A; Dépiscan Group.

Lung Cancer. 2007 Oct;58(1):50-8. Epub 2007 Jul 12.

PMID:
17624475
18.

[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer].

Westeel V, Lebitasy MP, Mercier M, Girard P, Barlesi F, Blanchon F, Tredaniel J, Bonnette P, Woronoff-Lemsi MC, Breton JL, Azarian R, Falcoz PE, Friard S, Geriniere L, Laporte S, Lemarie E, Quoix E, Zalcman G, Guigay J, Morin F, Milleron B, Depierre A; Intergroupe Francophone de Cancerologie Thoracique (IFCT).

Rev Mal Respir. 2007 May;24(5):645-52. French.

PMID:
17519819
19.

Lung cancer in patients with HIV Infection and review of the literature.

Spano JP, Massiani MA, Bentata M, Rixe O, Friard S, Bossi P, Rouges F, Katlama C, Breau JL, Morere JF, Khayat D, Couderc LJ.

Med Oncol. 2004;21(2):109-15. Review.

PMID:
15299182
20.

[Chest diseases in elderly: role of imaging and clinical features].

Scherrer A, Couderc JL, Friard S, Le Blanche A.

J Radiol. 2003 Nov;84(11 Pt 2):1829-36. Review. French.

PMID:
14739839
21.

Detection of pelvic vein thrombosis by magnetic resonance angiography in patients with acute pulmonary embolism and normal lower limb compression ultrasonography.

Stern JB, Abehsera M, Grenet D, Friard S, Couderc LJ, Scherrer A, Stern M.

Chest. 2002 Jul;122(1):115-21.

PMID:
12114346
22.

[Bone mineral density in patients with chronic lung diseases].

Brousse C, Nguyen-Plantin S, Friard S, Grenet D, Stern M.

Rev Mal Respir. 2001 Sep;18(4 Pt 1):411-5. French.

PMID:
11547249
23.

Nebulized cyclosporine in the rat: assessment of regional lung and extrapulmonary deposition.

Blot F, Faurisson F, Bernard N, Sellam S, Friard S, Tavakoli R, Carbon C, Stern M, Bisson A, Pocidalo JJ, Caubarrere I.

Transplantation. 1999 Jul 27;68(2):191-5.

PMID:
10440386
24.

Predictive value of cytomegalovirus DNA detection by polymerase chain reaction in blood and bronchoalveolar lavage in lung transplant patients.

Stéphan F, Fajac A, Grenet D, Honderlick P, Ricci S, Frachon I, Friard S, Caubarrere I, Bernaudin JF, Stern M.

Transplantation. 1997 May 27;63(10):1430-5.

PMID:
9175806
25.

[Cytomegalovirus pneumopathies. What role should be given to cytomegaloviruses isolated from blood and bronchoalveolar lavage fluid in AIDS and from organ and bone marrow grafts?].

Blot F, Mayaud C, Frachon I, Couderc LJ, Stern M, Friard S, Caubarrère I.

Rev Pneumol Clin. 1995;51(6):309-20. Review. French.

PMID:
8746018
26.

[Pulmonary pneumocystosis revealing HIV infection].

Luchon L, Couderc LJ, Stern M, Friard S, Caubarrere I.

Presse Med. 1994 May 28;23(20):951. French. No abstract available.

PMID:
7937635
27.

[Apropos of the treatment of chronic eosinophilic pneumonia].

Friard S, Jagot JL, Caubarrere I.

Presse Med. 1989 Jun 10;18(23):1169. French. No abstract available.

PMID:
2525756
28.

[Role of thoracic x-ray computed tomography in the pretherapeutic evaluation of bronchial cancer. A prospective study of 60 patients].

Milleron B, Friard S, Carette MF, Frija J, Herman D, Akoun G.

Rev Pneumol Clin. 1986;42(3):125-32. French.

PMID:
3775174

Supplemental Content

Loading ...
Support Center